Work

Cross-reactivity between vancomycin, teicoplanin, and telavancin in patients with HLA-A∗32:01–positive vancomycin-induced DRESS sharing an HLA class II haplotype

Year: 2020

Type: article

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2020.04.056

Authors: Nontaya Nakkam, Andrew Gibson, Effie Mouhtouris, Katherine C. Konvinse, Natasha E. Holmes, Kyra Y. Chua, Pooja Deshpande, Danmeng Li, David A. Ostrov, Jason Trubiano, Elizabeth J. Phillips

Institutions: Khon Kaen University, Vanderbilt University, Vanderbilt University Medical Center, Murdoch University, The University of Melbourne, Austin Health, The University of Western Australia, University of Florida Health, University of Florida, Peter MacCallum Cancer Centre

Language: English

Topic: Drug-Induced Adverse Reactions

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Health and Medical Research Council, National Human Genome Research Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases

Awards: G2310098089, NATIENS: A Phase III Randomized Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis, G2674209210, Medical Scientist Training Program, Single Cell definition of pathogenic T cells in Drug-induced Stevens-Johnson-Syndrome/Toxic epidermal necrolysis, Immunopathogenesis of nevirapine-induced severe T-cell-mediated adverse drug reactions

OpenAlex ID: W3028035015

FWCI: 4.062

Cites: 9

Cited by: 36

Related to: 10